SCOLR Pharma, Inc. To Present At Taglich Brothers 3rd Annual Small Cap Equity Conference

Taglich Brothers, Inc. is pleased to announce that Daniel Wilds, President & CEO of SCOLR PHARMA, INC. (AMEX: DDD) will be presenting at our 3rd Annual Small Cap Equity Conference May 2nd, 2006. The Conference will take place at the Le Parker Meridien, New York City. The company will present at 4:00PM in the Azekka Room. To request additional information or to register, contact Taglich Brothers at 212-779-2214 or visit www.taglich.com.
MORE ON THIS TOPIC